Bhakti has over 15 years of experience in biotech, consulting, and financial services spanning corporate finance, business development, strategy, and business process re-engineering.
Prior to ElevateBio, Bhakti was Head of Global Commercial Finance at Alexion Pharmaceuticals, where she worked closely with therapeutic areas to support development, implementation, and execution of global franchise strategy and brand planning. Bhakti previously worked for J.P Morgan in strategy, business management, and treasury as part of the Corporate Finance team in Investment Banking and Asset Management.
Bhakti holds an MBA from Cornell University where she was an Albert Fried, Jr. Fellow and a BS in Computer & Electrical Engineering from Purdue University.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
